Autopsy report · NCT03263767

Post Transplant Cyclophosphamide (PTCY) as Sole Graft Versus Host Disease (GVHD) Prophylaxis for Matched Allotransplant: CYRIC

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Security criteria (MTD)”

The sponsor’s own words in the registry.

Life of this trial

Registered 5 months before it started.
Ran for about 4 years 5 months before it stopped.
47 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: Nantes University Hospital
Sponsor type: University, hospital or other
Conditions: Graft Versus Host Disease
Interventions: Fludarabine; Clofarabine; Full body irradiation; Cyclophosphamide; Cyclophosphamide; stem cell transplantation
Participants: 47
Sites: 1
Countries: France

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.